Acquisitions31 Jan 2026, 04:03 am
MPS Ltd Subsidiary Acquires Unbound Medicine, Inc. for USD 16.50 Million
AI Summary
MPS North America LLC, a wholly owned subsidiary of MPS Ltd, has entered into a Stock Purchase Agreement to acquire 100% stake in Unbound Medicine, Inc., a U.S.-based healthcare learning technology company, for a total consideration of USD 16.50 Million. The acquisition aligns with MPS’ long-term strategy of scaling platform-led businesses while accelerating value creation through AI and domain-specific adjacencies.
Key Highlights
- MPS North America LLC to acquire 100% stake in Unbound Medicine, Inc.
- Total consideration of USD 16.50 Million
- Unbound Medicine, Inc. is a U.S.-based healthcare learning technology company
- Acquisition aligns with MPS’ long-term growth strategy
- Unbound Medicine operates on a subscription-led model with ~97% gross retention